Back to Search
STERGIOS MOSCHOS, MD
MD
Hematology & Oncology Physician
NPI: 1255305918IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
2011-01759(NC)
Education
OTHER
Class of 1997
Research & Publications (20)
Focus on FOCIS: interleukin 2 treatment associated autoimmunity.
PMID 18405863·Clin Immunol·2008
5-case
Endostatin plus interferon-alpha2b therapy for metastatic melanoma: a novel combination of antiangiogenic and immunomodulatory agents.
PMID 17505265·Melanoma Res·2007
3-trial
SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomas.
PMID 17297476·Oncogene·2007
8-other
Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responses.
PMID 16809739·J Clin Oncol·2006
3-trial
Modulating the adjuvanticity of alum by co-administration of muramyl di-peptide (MDP) or Quil-A.
PMID 16219395·Vaccine·2006
7-preclinical
Comparative immunomodulatory properties of a chitosan-MDP adjuvant combination following intranasal or intramuscular immunisation.
PMID 15734064·Vaccine·2005
4-observational
Adjuvant synergy: the effects of nasal coadministration of adjuvants.
PMID 15550121·Immunol Cell Biol·2004
7-preclinical
Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays.
PMID 19499548·Int J Cancer·2009
8-other
The use of endostatin in the treatment of solid tumors.
PMID 19368526·Expert Opin Biol Ther·2009
6-review
Immunogenicity and antitumor effects of vaccination with peptide vaccine+/-granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696.
PMID 19228745·Clin Cancer Res·2009
3-trial
Does pegylated interferon alpha-2b confer additional benefit in the adjuvant treatment of high-risk melanoma?
PMID 19092800·Nat Clin Pract Oncol·2009
8-other
Targeting the lung using siRNA and antisense based oligonucleotides.
PMID 19075738·Curr Pharm Des·2008
6-review
Role of miRNA-146a in the regulation of the innate immune response and cancer.
PMID 19021527·Biochem Soc Trans·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5115 CENTRE AVE, UPMC CANCER PAVILLION
PITTSBURGH, PA 15232 - Phone
- (412) 623-2294
Quick Facts
- NPI
- 1255305918
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile